The antigenicity of synthetic polymers of a-amino acids has been studied in various species for different reasons. The original impetus to these investigations was the search for highly polymerized protein-like materials that could possibly be used as plasma volume expanders. Interest in these materials has increased since their anfigenicity offers a means of determining the minimum structural requirements for anfigenicity in protein-like materials. By the application of quantitative immunochemical studies with small polypeptides it may be possible to determine the size and structure of the antigenic unit and the nature of combining sites in the antibody.
PLATES 70 TO 73
(Received for publication, June 11, 1962) The antigenicity of synthetic polymers of a-amino acids has been studied in various species for different reasons. The original impetus to these investigations was the search for highly polymerized protein-like materials that could possibly be used as plasma volume expanders. Interest in these materials has increased since their anfigenicity offers a means of determining the minimum structural requirements for anfigenicity in protein-like materials. By the application of quantitative immunochemical studies with small polypeptides it may be possible to determine the size and structure of the antigenic unit and the nature of combining sites in the antibody.
Previous reports have dealt with the antigenicity in humans of synthetic poly-a-glutamic acid (1) and random copolymers of glutamic acid and lysine (2) . The present report will deal with the study in humans of additional copolymers consisting of 3 and 4 amino acids. The anfigenicity of the 4 polymers used in this study has been established previously in rabbits (3) and guinea pigs (4) .
Materials and Methods
The copolymers studied for antigenicity in humans are listed in Table I . The methods used in preparing the materials and the techniques employed in determining the average molecular weights are presented in references 5-10. After withdrawal of 50 ml of blood the human volunteers were skln-tested with 0.1 ml of polymer solutions of 10 mg/ml and 1 mg/ml and 0.1 ml of the 0.15 ~ saline buffer. The individuals then received 5 intramuscular injections of the appropriate polymer solutions given over a period of 10 days. With antigens GLA5 and GLT a total of 125 mg was injected into 6 and 5 individuals respectively. With antigens GLA40 and GLAT, 6 individuals in each group received a total of 12.5 mg and other groups of 6 received 125 mg. The bleedings and skin testings were repeated about 12 and 21 days after the last injection. Because of the responses noted, the bleedings and testings were repeated for with buffered saline and then resuspended to the original volume (2.5 per cent). The tanned cells were used to absorb the antisera before titration. For preparing the antigen-coated cells, the tanned cells were centrifuged and resuspended in 1 ml of buffered saline, pH 6.4. a The appropriate antigen was dissolved in adjusted saline (2 mg copolymer per ml tanned RBC suspension). 4 mlpH 6.4 buffered saline was then added to the cell suspension and the mixture incubated at room temperature for 30 minutes. The suspension was centrifuged and the cells washed 3 times with 1 or 2 ml volumes of 1 : 100 normal human serum (previously absorbed with tanned cells) and resuspended to the original concentration of 2.5 per cent. The normal human serum used above and in the dilutions of sera was first absorbed in a 1:10 concentration and diluted to 1:100 with buffered saline.
Antisera dilutions (0.5 ml) were added to 13 X 100 mm tubes. To the serum was added 0.05 ml antigen-treated tanned cells. The cells were suspended and the tubes allowed to stand at room temperature for several hours and then overnight at 5°C. Controls included antigentreated tanned cells mixed with 1:10 and 1:100 dilutions of normal serum and tanned ceils mixed with the lowest dilution of antiserum used. Readings were made after 3 hours at room 1 Prepared by mixing equal amounts of 0.15 ~ NaC1 and a mixture of 0.15 ~ NasHPO4 and 0.15 M KH2PO4.
Prepared in buffered saline from a stock solution of 1 per cent tannic acid in buffered saline.
Several other pH's were studied and this pH was found to be optimal.
temperature and the following morning after removal of the tubes from the cold room. The results were graded according to the procedure used by previous workers. The final hemagglutination titers (HA) recorded in the tables are those dilutions of antiserum in which a thin film of cells covered the entire bottom of the tube. The PCA test in guinea pigs was performed on all sera as described by Ovary (14) . 0.1 ml of undiluted serum was injected intradermaily into guinea pigs weighing 200 to 250 gm. 3 hours later, 1 ml of a solution containing 250 ug of the appropriate copolymer and 0.5 per cent Evans blue dye solutions was injected intravenously. The blueing reactions which were present after 20 minutes at the site of the serum injection were recorded.
For studies of passive systemic anaphylaxis, guinea pigs weighing 200 to 250 gm were given intraperitoneai injections of sera containing about 40 ~g Ab N (antibody nitrogen). The guinea pigs were injected intravenously 48 hours later with 2 mg of the homologous polymer and observed for signs of anaphylaxis.
Sera from someof thegood reactors were passively transferred to normal volunteers. 0.1 ml aliquots of undiluted serum was injected intradermally in the forearm. 24 hours later the original sites were injected with the appropriate antigen or 0.15 M NaCI. Additional virgin areas were injected with antigen alone.
Biopsies of immediate and delayed skin reactions were obtained by sterile surgical procedures, fixed in formalin for histological sectioning, and stained with hematoxylin and eosin and trichrome.
Some of the reactors were tested for cross-skin reaction with several of the polymers of 2 and 3 amino acids which were discussed in previous reports (Table IV) .
RESULTS
During the immunization, several individuals had systemic reactions. Volunteer 55(GLA5) 4 had a flare-up reaction at the original skin test site 2 days after the last injection. One day after the last injection individual 63 (GLT) had a flare-up reaction at the initial skin test site (Fig. I) . In addition, the site of the last injection was hard and warm. The individual reported a generalized urticarial reaction with stiffening of the wrists, knees, ankles, and elbow joints. The reaction was relieved after 2 days of treatment with antihistamines. Volunteer 50 (GLA40) reported that the day after the last injection, the injection site became sore, tender, and red. A reddened area of about I0 inches long X 5 inches wide devdoped which persisted for 2 days and then gradually disappeared. Volunteer 52 (GLA40) noticed that 6 hours after the last injection, a red area (100 X 120 ram) developed at the site of the injection. Considerable dii~culty was experienced in flexing the arm. The red area became larger the following day and then the inflammation gradually disappeared. The most severe systemic reactions were associated with injections of GLAT. After the 4th injection individual 41 reported that his arm was red at the injection site (200 X 50 nun) and was slightly febrile. Blood was taken and checked for possible bacterial contamination. None was found either in the individual's blood or in the antigen being injected. The individual was then skin-tested. An immediate erythematous reaction 40 X 40 mm with a I0 mm wheal de-veloped. Within 2 hours the skin test area was completely clear. However, in 5 hours redness began to appear and spread. The test site at 24 hours measured 140 X 100 mm, at 72 hours 160 X 125 ram, and at 96 hours 180 X 140 mm. By 5 to 6 days the inflammation had completely disappeared. Other systemic reactions to GLAT were reported by individuals 34 and 38. Both complained of tenderness and inflammation at the injection site the evening of the injection.
Table II presents the data on the skin reactions observed after immunization. Because of the extent of the reactions, they are recorded according to the average diameter in millimeters of the erythema, rather than on a 0 to 4+ basis. Whealing reactions are also recorded. There were no positive skin reactions before immunization. The results are presented only for the 10 mg/ml test dose. There were no immediate skin reactions against GLA5. However on day 12, there were 3 good and 2 mild delayed reactions. The delayed reactions were still present at 72 hours with individuals 55 and 56 (40 and 30 mm reactions, respectively). On day 21 only no. 55 showed a delayed reaction. There was a greater response against the GLT polymer. Of the 5 volunteers, 2 showed good immediate reactions on day 12. These same 2 individuals had good delayed reactions and another 2 showed fair reactions. Similar reactions were present on day 21. With the GLA40 polymer on day 12 there were 6 strong immediate reactions (Nos. 43, 45, 46, 49, 50, 52) and 5 mild reactions followed by 10 strong and 2 weak delayed reactions. Individuals 42, 43, 45, 46, 47, 49, and 52 still had good reactions at 72 hours. When tested on day 21 there was not much change in the number or extent of the reactions. There was no significant difference between the two groups receiving the same antigen. The GLAT copolymer produced the greatest responses. On day 12, 11/12 individuals had good immediate reactions and 12/12 showed good delayed reactions which were still present at 72 hours in all individuals except 40. Here, too, on day 21 there was no major change from the skin reactions noted on day 12. The course of the immediate and delayed reactions in all individuals showing both reactions was similar; i.e., within 1 to 2 hours after skin testing the marked immediate reactions were gone and the skin remained clear for several hours. About 6 to 10 hours later there was a return of another reaction which was uniform in redness and persisted for at least 72 hours. In repeated testing of the sensitive individuals, the same sort of skin reactivity persisted for several months. Figs. 2 to 4 show representative pictures of the immediate, 3 hour, and 24 hour reactions. Histological examination of the biopsies of several immediate and delayed skin reactions was undertaken. The immediate reactions showed marked edema with infiltration of polymorphonuclear cells. The inflammatory reaction was acute in nature and did not damage the vessel walls (Fig. 5) . The delayed reactions showed a heavy perivascular lymphocytic infiltration (Figs. 6, 7) .
The micrograms of antibody N precipitated by antigen from the 12 and 21 day serum samples are presented in Table II along with hemagglutination titers. No antibody was precipitated from the preimmunization sera nor were significant HA titers obtained on the sera. It will be noted that 2 individuals (55, 57) produced significant amounts of antibody by day 12 against GLA5 and that the values decreased by day 21. Similar observations were noted with the HA results. Only these 2 individuals had weak titers. The response in the GLT groups was fair. Individuals 61 and 63 produced very high levels of antibody by day 12 (>40 ~g Ab N/ml) and their sera gave HA fiters of 75 and 400, respectively. The antibody level of the serum of No. 60 was at the limit of detectability of both methods. By day 21, the antibody level had dropped about 50 per cent with both individuals. In the GLA40 group good levels of antibody N were detected on day 12 in 10 of the 12 volunteers. The levels of antibody on day 21 in some cases decreased (Nos. 42, 43) but in most instances remained at the same level as the day 12 bleedings. Only No. 51 showed a significant increase in antibody from 0.6 ~g N to 6.0/~g N/ml.
The hemagglutination titers showed a fair correlation with the antibody values. Individuals 49 and 50 had the highest HA titers (500 and 1000), 48 and 51, low fiters (50 and 100), and the other individuals had intermediate fiters (200 to 500). Individual 42 showed a significant decrease in antibody level on day 21 as well as a decrease in HA titer.
In the GLAT group, good levels of antibody were obtained with 11/12 sera on day 12. Only No. 35 produced very low levels of precipitating antibody (less than 2 #g N/ml). When measured on day 21, it was noted that some individuals had a decline in antibody levels (Nos. 32, 38, 40), some had a significant increase in the antibody level (Nos. 30, 34, 36, 41), and with others the level remained constant. The HA titers were somewhat parallel to the preclpitin values but did reflect the inherent errors of the qualitative HA test. Differences of a tube in titration could not be considered significant.
The data obtained with repeated bleedings from some of the best reactors are presented in Table III . In most cases the antibody level decreased with time. However, individual 50 exhibited the slowest decline. The last 2 bleedings from this individual taken 6 weeks apart showed the same antibody level. Moderate Ab N levels were present in individuals 41, 49, 61 and 63 on March 19, 1962 , but most of the other volunteers showed no levels of precipitating antibody and negligible HA titers.
Some of the supernatants from the precipitin analysis were also tested with tanned cells. There were definite reductions in the HA titers in cell-absorbed sera.
The results of testing the sera by PCA are presented in Table II . None of the sera from the GLA5 group gave positive reactions. In the GLT group the serum from individual 61 gave a positive PCA reaction on day 12 and individual 63 was positive on days 12 and 21. In the GLA40 group on day 12 sera from 46, 49, 50, and 52 and on day 21 sera from 46, 50, and 52 gave good PCA reactions.
Why serum 40 with 53.5 #g Ab N/ml did not give a reaction is not known at present, but will be discussed later. Subsequent bleedings were also tested and only Nos. 46 and 50 with 26.0 and 22.6 #g Ab N per ml of serum gave positive * Values in parentheses refer to HA titers obtained after absorption of serum with antigen. :~ Sera used for passive anaphylaxis studies in guinea pigs.
reactions, whereas sera 45, 49, and 52 with 21.8, 19.5 and 11.6 #g Ab N per ml, respectively did not give positive PCA reactions with undiluted serum. In the GLAT group positive PCA reactions with the day 12 bleedings were given by Nos. 30, 37, 38, and 41. Positive reactions were also obtained with the day 21 bleedings from the individuals, with the exception of No. 36 who had 48.8 #g Ab N/ml serum. When subsequent bleedings taken about 2 months later were tested only No. 41 gave a positive PCA reaction although there were 10 to 20 #g Ab N/ml serum in some of the sera that did not give PCA reactions.
None of the guinea pigs injected with 40 #g antibody N from the sensitized individuals showed any signs of systemic anaphylaxis when challenged with the antigen. The sera used are indicated in Table III . The sera that were used to determine whether the P-K type of antibody was present were those from individuals 31, 35, 38, 40 and 41 for the GLAT group and from individuals 42, 45, 49, 50 and 53 in the GLA40 group. Each normal recipient received several intradermal injections of serum from 2 recipients. Pre-and postimmunization, antigen-absorbed, and heated sera were injected. In no case was a positive P-K reaction noted upon injection of antigen 24 hours later into the test sites.
As part of the interest in the specificity of the in vivo reactions, some of the individuals in the GLA40 and GLAT groups were skin tested, with several of the polymers listed in Table IV . Representative results obtained are shown in Table V . It will be seen that in the GLA40 group in general, good cross-reactions, both immediate and delayed were shown by GLAT and GA. Three individuals (50, 51, 52) showed reactions against GLA5 and GL. Two of these (50, 51) also showed reactions with G. No reactions were obtained with GLT in this group. In the GLAT group, good cross-skin reactions were shown with GLA40 and GA. Four individuals showed immediate reactions against GLA5, three against GLT and two against GL. Only one individual (No. 41), who was the best reactor in the group, showed a good skin reaction with poly G. In no case were reactions noted in either group with the control diluent (0.15 ~t NaC1).
DISCUSSION
The data indicate that polymers GLAT, GLA40, GLT, and GLA5 are antigenic for man in the order listed. Earlier studies have established the antigenicity of these polymers for rabbits (3) and guinea pigs (4) . As shown in a previous publication the glu-lys polymers were not antigenic in humans under the same conditions of immunization and testing (2) . This would indicate that the introduction of a small amount of a third amino acid (5 tool per cent) into the glu-lys copolymers caused sufficient changes in the molecule to make it antigenic. From the limited number of individuals injected with GLA5 and GLT it appears that GLT was a better antigen and that tyrosine may be a good enhancer of antigenicity. However, the data we have presented in rabbits with these polymers and glu-ala (3) as well as the good response in the humans against GLA40 would indicate that tyrosine per se was not enhancing antigenicity. Other factors such as the formation of "foreign" polypeptide sequences and the possible stabilization of structures by alanine may play important roles in the nature of the immune response produced. In the development of the immune response as measured by skin reactivity in the humans, there appear to be two distinct reactions: an immediate type of reaction which is inflammatory in nature, and transient, and a delayed cellular reaction which may persist for several days. The latter reaction (cellular sensitivity) develops first; i.e., individuals who have little or no detectable antibody and no immediate reaction show good delayed reactions (individuals 56, 58, 59). There were however, several instances of good levels of precipitating antibody in the absence of immediate reactions (individuals 55, 57, 42, and 40) and also examples of good immediate skin reactions with very low levels of precipitating antibody (Nos. 51, 53, 35). In general, however, there was a fair correlation between the immediate type of skin reactivity and the antibody level. The studies of passive transfer of the serum into normal recipients did not indicate the presence of the P-K type of antibody. Included in these tests were the sera from individuals 35 and 53, who had good skin reactivity and low levels of precipitating antibody, and did not give a positive P-K reaction. None of the other sera used gave a positive transfer reaction. There was not too good a correlation between the levels of precipitating antibody and the HA titers. Even within responses to a given antigen, the antibody levels as measured by precipitin analysis varied sixfold with only twofold differences in HA titers of tanned red blood cells. There were also instances of low levels of antibody and high HA titers (Nos. 45, 46). It should be borne in mind that the HA fiters are only qualitative and that the titers depend not only on how much antibody is in the serum being analyzed, but also on how much antigen gets on the red cells, a variable which cannot be effectively controlled. It is hoped to couple the antigens to the red cells by covalent bonds (bis-diazotized benzidine or toluidine 2,4-diisocynate) to standardize the amount of each antigen on the cell. It is not known at present whether the same antibody responsible for precipitating activity is also responsible for the HA activity of the sera. The specificity of the HA reaction was shown by the negative titers with the preimmunization sera.
From the limited data presented on serially absorbed antisera it appears that it is possible some HA activity was still present in the supernatants. This problem is being studied further at present. It may be related to the reports of others that in the antigen-antibody systems with synthetic polymers not all of the antigen is precipitated at equivalence and that the supernatants still have soluble antigen-antibody complexes (15) (16) (17) . The results with the PCA reactions were also not clear cut. In contrast to the studies with rabbit antisera against the same copolymers, the sensitivity here with human sera is not very great. Most of the sera with less than 15/zg antibody N per ml did not give positive PCA reactions. One serum (No. 36) with 48.8 #g Ab N per ml also did not give a PCA reaction. This is in agreement with previous observations indicating that the method is less sensitive for detecting human antibody. Ovary has mentioned that with human sera if the concentration is 50 ug Ab N per ml then it is possible to detect antibody easily when the serum is diluted to about 12 ~g Ab N per ml (18) . In general, the PCA test for human antibody is 100 times less sensitive than for rabbit antibody and may be related to its inability to fix to sites in guinea pig skin (19) . Human gamma globulin also does not compete well with rabbit gamma globulin for fixation to guinea pig skin (20) . Another factor of importance which may explain the absence of PCA in the serum having 48 #g Ab N per ml is the inablity of antibody of 19S size to give a PCA reaction (21) . 19S antibody when present can inhibit the ability of 7S antibody to give a good PCA reaction. If the sera have mixtures of 7S and 19S antibody, reduced PCA titers can result. Studies are under way to fractionate the sera chromatographically and learn if antibody activity is associated with 19S components. Some indication that high molecular weight antibody may be in the human sera is based on the increased time needed for positive reactions to be obtained in agar diffusion compared with the time needed for the rabbit sera containing equivalent amounts of antibody.
The absence of systemic anaphylaxis in the guinea pigs given 40/~g antibody N would also be in agreement with the observations reported above on the PCA reactions.
The immune response against the copolymers resembled antiprotein reactions in the sense that the antibody levels did decrease rather than remain constant for a long period of time as has been found with antipolysaccharide levels in humans (22) (23) (24) . The half-life of the antibody level in the various individuals varied considerably from 2 to 6 weeks (25). However, it should be realized that the individuals were skin-tested at each bleeding with 100 #g of material and this injection may have promoted a booster response. With many of the sera not listed in Table II the antibody levels at the last testing (April, 1962) were not detectable by the precipitin reaction but these individuals still had definite immediate reactions and very good delayed reactions. The extent of the delayed skin reactions did not decrease much during the 5 month study but the immediate reactivity did decline as did the antibody level.
The data on the specificity of the individual responses against the copolymers as measured by skin reactions presented in Table V, indicate that there are several patterns to the response. This will be demonstrated further in subsequent publications dealing with the immunochemical studies of cross-reactions of various copolymers with these antisera. With the anti-GLA40 sera there were good cross-skin reactions with GLAT and GA showing that these 3 polymers have determinant groups in common. The fact that some of the individuals reacted to GLA5, GL, and also poly G indicates a non-uniformlty in response against the mixed copolymer. This has been shown to be true of these types of copolymers in rabbits and guinea pigs (3, 4) . Not all individuals exposed to an antigen will necessarily react against the same determinant groupings. Some individuals have reacted against GA groupings, other against GL, and still others against poly G. The same sort of situation obtains with the anti-GLAT sera. More will be learned about the nature of the specific antigenic groupings from inhibition studies with di-, tri-, tetra-, etc. peptides of different amino acids.
As for the practical application of the findings in this report, it appears that the introduction of 5 tool per cent a third amino acid (alanine or tyrosine into the glu-lys polymer) removes the polymer from consideration as a plasma expander. Whether the introduction of other neutral or polar amino acids will enhance the antigenicity of the glu-lys copolymer is contemplated for study in the near future.
SUMMARY
It has been shown that the polymers GLA5, GLT, GLA40, and GLAT are antigenic in human beings. Both immediate skin reactions and delayed (cellular) reactions were observed.
The antibody produced reacted well in the precipitin reaction, agglutinated antigen coated tanned sheep cells, was less effective in inducing PCA reactions, and failed to sensitize guinea pigs for passive systemic anaphylaxis.
The immediate skin reactivity appeared not to be related to the P-K antibody. The delayed reaction was histologically distinct from the immediate reaction and consisted of perivascular lymphocytic infiltration in contrast to the predominantly polymorphonuclear cells in the latter reaction. The antigenic response against the polymers resembled that observed with proteins. From cross-reactions it appears that the response is heterogeneous in the sense that not all individuals react against the same groupings in the complex polymers. 
